Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response

Myeloid Dendritic Cells ◽

Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2021.103435 ◽

2021 ◽

pp. 103435

Author(s):

Magdalena Krbot Skorić ◽

Dunja Rogić ◽

Ivana Lapić ◽

Dragana Šegulja ◽

Mario Habek

Keyword(s):

Multiple Sclerosis ◽

Immune Response ◽

Humoral Immune Response ◽

Humoral Immune ◽

Case Report: Fecal Microbiota Transplantation Associated with 10 Years of Disease Stability in a Patient with Secondary Progressive Multiple Sclerosis

10.26226/morressier.59a3edaad462b8028d894a3a ◽

2017 ◽

Cited By ~ 1

Author(s):

Seraj Makkawi

Keyword(s):

Multiple Sclerosis ◽

Case Report ◽

Fecal Microbiota Transplantation ◽

Fecal Microbiota ◽

Novel Integrative Approach Combining Patient, Physician and Empirical Assessments for Diagnosing Secondary-Progressive Multiple Sclerosis

10.26226/morressier.59a3e8b4d462b8028d894594 ◽

2017 ◽

Author(s):

Daniela Piani Meier

Keyword(s):

Multiple Sclerosis ◽

Integrative Approach ◽

Faculty Opinions recommendation of Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718321526.793500099 ◽

2014 ◽

Author(s):

Helmut Wilhelm

Keyword(s):

Multiple Sclerosis ◽

Brain Atrophy ◽

High Dose ◽

Phase 2 ◽

Secondary Progressive ◽

Phase 2 Trial

Interferon beta for secondary progressive multiple sclerosis

10.1002/14651858.cd005181.pub2 ◽

2009 ◽

Author(s):

Loredana La Mantia ◽

George Ebers ◽

Sten Fredrikson ◽

Graziella Filippini

Keyword(s):

Multiple Sclerosis ◽

Interferon Beta ◽

Clinical and radiological activity of secondary progressive multiple sclerosis in a population‐based cohort

European Journal of Neurology ◽

10.1111/ene.14861 ◽

2021 ◽

Author(s):

Guillaume Mathey ◽

Thomas Ancel ◽

Teresa Garot ◽

Marc Soudant ◽

Sophie Pittion‐Vouyovitch ◽

...

Keyword(s):

Multiple Sclerosis ◽

Population Based ◽

Siponimod for treating secondary progressive multiple sclerosis

Prescriber ◽

10.1002/psb.1882 ◽

2020 ◽

Vol 31 (11-12) ◽

pp. 34-35

Author(s):

Steve Chaplin

Keyword(s):

Multiple Sclerosis ◽

Correction to: Siponimod: A Review in Secondary Progressive Multiple Sclerosis

CNS Drugs ◽

10.1007/s40263-020-00785-7 ◽

2021 ◽

Vol 35 (1) ◽

pp. 133-133

Author(s):

Lesley J. Scott

Keyword(s):

Multiple Sclerosis ◽

The 'Immunological-Synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-β

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2003.08.002 ◽

2003 ◽

Vol 144 (1-2) ◽

pp. 116-124 ◽

Cited By ~ 30

Author(s):

S Shapiro

Keyword(s):

Multiple Sclerosis ◽

Immunological Synapse ◽

Interferon Β ◽

Novel mechanisms of chronic inflammation in secondary progressive multiple sclerosis

Clinical and Experimental Neuroimmunology ◽

10.1111/cen3.12437 ◽

2018 ◽

Vol 9 ◽

pp. 13-19

Author(s):

Shinji Oki

Keyword(s):

Multiple Sclerosis ◽

Chronic Inflammation ◽